Your browser doesn't support javascript.
loading
Hemizygous loss of function mutations in CLCN5 causing end-stage kidney disease without Dent disease phenotype.
Leggatt, Gary; Gast, Christine; Gilbert, Rodney D; Veighey, Kristin; Rahman, Tahmina; Ennis, Sarah.
  • Leggatt G; University of Southampton, Southampton, UK.
  • Gast C; Wessex Kidney Centre, Portsmouth, UK.
  • Gilbert RD; University of Southampton, Southampton, UK.
  • Veighey K; Wessex Kidney Centre, Portsmouth, UK.
  • Rahman T; University of Southampton, Southampton, UK.
  • Ennis S; Southampton Children's Hospital, Southampton, UK.
Clin Kidney J ; 16(1): 192-194, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36726441
ABSTRACT
Dent disease type 1 is suspected in the presence of a complete phenotype of low molecular weight (LMW) proteinuria, hypercalciuria and at least one of the following nephrocalcinosis, nephrolithiasis, haematuria, hypophosphatemia or chronic kidney disease (CKD). We present two brothers who presented with CKD alone. In the absence of typical clinical features, further assessment of LMW proteinuria and hypercalciuria was not undertaken. Whole-genome sequencing revealed hemizygous loss of function mutations in chloride voltage-gated channel 5 (CLCN5) consistent with Dent disease. Dent disease should, therefore, be considered in patients with an incomplete phenotype, including unexplained CKD alone.
Palabras clave